P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Background: P2Y12 inhibitor monotherapy is an alternative antiplatelet strategy in patients undergoing percutaneous coronary intervention (PCI). However, the ideal P2Y12 inhibitor for monotherapy is unclear. Methods and Results: We performed a multicenter, retrospective, observational study to compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Po-Wei, Feng, Wen-Han, Ho, Ming-Yun, Su, Chun-Hung, Huang, Sheng-Wei, Cheng, Chung-Wei, Yeh, Hung-I, Chen, Ching-Pei, Huang, Wei-Chun, Fang, Ching-Chang, Lin, Hui-Wen, Lin, Sheng-Hsiang, Hsieh, I-Chang, Li, Yi-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355760/
https://www.ncbi.nlm.nih.gov/pubmed/32492818
http://dx.doi.org/10.3390/jcm9061657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355760/
https://www.ncbi.nlm.nih.gov/pubmed/32492818
http://dx.doi.org/10.3390/jcm9061657

Ejemplares similares